A drink containing liquid aspirin could extend the lives of thousands of brain cancer patients, according to breakthrough research.
British experts have found that the simple drug can cross the ‘blood-brain barrier’ — a hurdle which has so far stopped cancer drugs attacking brain tumours.
Scientists will today announce the results of early tests which show liquid aspirin is ten times more effective than any existing chemotherapy at killing brain cancer cells.
Read more
Comments are closed.